Paracoccidioidomycosis is a major systemic mycosis in Central and South America (7, 12, 25) . The causative agent is the thermally dimorphic fungus Paracoccidioides brasiliensis. Its mode of transmission and habitat have not yet been determined (13, 23) . The condition is a chronic granulomatous disease characterized by primary pulmonary lesions with dissemination to visceral organs, particularly the reticuloendothelial system, and by ulcerative granulomas of the skin and mucous membranes (9) .
Because of the wide range of clinical presentations, the diagnosis of paracoccidioidomycosis is based on the finding of characteristic multiple budding yeasts in sputum, biopsy material, or samples taken from cutaneous ulcers by direct examination (10, 19, 20) or by culture of P. brasiliensis and serology (3, 6, 11, 13, 17) . Antibodies to P. brasiliensis can be detected by a number of serological techniques such as immunodiffusion (3, 21) , complement fixation (18) , indirect immunofluorescence (1, 16, 24) , immunoelectrophoresis, and enzyme-linked immunosorbent assay (ELISA) (5, 19) . However, antigenic similarities between the dimorphic fungi result in serological cross-reactivities when existing P. brasiliensis antigens are used in these tests, particularly between P. brasiliensis and Histoplasma capsulatum (12, 16) , often leading to false-positive results. There is a similar problem in using existing antigens as skin test reagents to study the epidemiology of the infection (5, 12, 18, 21) .
The problem of cross-reactivity has, in turn, hindered the production of species-specific monoclonal antibodies which could be used to define species-specific epitopes. The major components of fungal cross-reactivity are immunodominant carbohydrates which are present in the cell wall of different fungi. Recently, Hamilton and co-workers (lla; A. J. Hamilton, M. A. Bartholomew, L. E. Fenelon, J. I. Figueroa, and R. J. Hay, Trans. R. Soc. Trop. Med. Hyg., in press) have used a modification of an immunosuppressive technique directed against immunodominant epitopes (15, 27) to raise species-specific monoclonal antibodies aganist H. capsulatum var. capsulatum and, so, to overcome the difficulties provided by these carbohydrate epitopes. Here we report the successful use of this technique to produce speciesspecific P. brasiliensis monoclonal antibodies. made up in a 1:1 ratio in Freund incomplete adjuvant was given. An identical inoculation was given on day 17. Five days later a blood sample was taken from the tail vein of each mouse, and their sera were screened by ELISA (described below), to find the individual mouse with the highest differential polyclonal response to H. capsulatum and P. brasiliensis antigens. This individual mouse received an intravenous inoculation of P. brasiliensis antigen in PBS (50 ,ug of total protein) and was then used for the fusion protocol on day 25.
Fusion protocol. Cells of the murine myeloma line sp 2/0 were fused with spleen cells from the test mouse in a ratio of 1:10 by the modified protocol of Zola and Brooks (30) by using polyethylene glycol 4000. Hybridomas were then distributed to 96-well plates (Linbro), and at 10 days postfusion colonies were screened by a differential ELISA. P. brasiliensis and H. capsulatum var. capsulatum antigen in 0.06 M carbonate buffer (pH 9.6) was used to coat 96-well microdilution plates at a protein concentration of 1 ,ug per well (100 ,ul per well) overnight at 4°C. Wells absolute discrimination between the two antigens were then expanded into 24-well plates and subcloned twice by limiting dilution before a final expansion into a 25-ml culture flask. Culture supernatants were also assayed for reactivity against the other fungal cytoplasmic antigens by ELISA, as appropriate. BALB/c mice which were primed with pristane were inoculated with 104 cells from each monoclonal antibody line, and ascitic fluid was collected over a period of 1 week after the development of ascites.
Polyacrylamide gel electrophoresis, electroblotting, and immunoenzyme development. A modification of the method of Tsang and co-workers (28) was used for polyacrylamide gel electrophoresis, electroblotting, and immunoenzyme development. The original preparations of dimorphic fungal antigens containing protease inhibitors were boiled for 2 to 5 min and treated with 2-mercaptoethanol and sodium dodecyl sulfate. In addition, a standard preparation of histoplasmin (L. Kaufman, Mycotic Diseases Division, Centers for Disease Control, Atlanta, Ga.) was prepared in this way for electrophoresis.
Samples were then electrophoresed in a Tris-glycinesodium dodecyl sulfate running buffer at a concentration of 100 ,ug of protein per gel by using a Mini Protean II cell ( 10 inoculated mice indicated that 1 mouse produced antibody with high differential activities against P. brasiliensis and H. capsulatum antigens, with a much higher reactivity toward P. brasiliensis. This was the mouse that was selected for the fusion protocol. Figure 1 shows the optical densities at 492 nm plotted against the dilutions of sera for the reactivity of the sera of this mouse against the two antigens.
The ELISA was performed 7 days postfusion and revealed more than 50 colonies with a high specificity toward P. brasiliensis antigens, when read by visual inspection. After consecutive subcloning, four monoclonal antibodies were obtained; these were designated P4, 7E2, 7B9, and 2E2. Figure 2 shows the differential reactivities of these monoclonal antibodies toward P. brasiliensis, H. capsulatum, B. dermatitidis, and S. schenckii antigens by ELISA. Monoclonal antibody P4 showed a strong recognition of all three P. brasiliensis isolates but no reactivity against any of the other isolates of fungal species antigens. Negative controls showed a cutoff optical density value of 0.2. Monoclonal antibodies 7E2, 7B9, and 2E2 showed no cross-reactivity with the other fungal antigens, although they exhibited much lower titers to P. brasiliensis.
Western blot (immunoblot) analysis of monoclonal anti- 
DISCUSSION
The results of the differential ELISA performed with the polyclonal mouse serum, which showed a much higher reactivity toward P. brasiliensis, established the effectiveness of immunomodulation with cyclophosphamide in the production of monoclonal antibodies. The possible mechanisms underlying this immunomodulation have previously been described in detail (lia, 15, 27; Hamilton et al., Trans. R. Soc. Trop. Med. Hyg., in press). The success of the polyclonal response was mirrored in the 50 or more different clones that were detected in the first screening after fusion as colonies with high reactivities toward the P. brasiliensis antigen but with very low or no reactivity toward the H. capsulatum antigen; that, in itself, is remarkable, given the previous attempts to raise species-specific monoclonal antibodies against fungi.
Monoclonal antibodies P4, 7E2, 7B9, and 2E2 are the first species-specific monoclonal antibodies toward P. brasiliensis demonstrated by ELISA and, in the case of monoclonal antibody P4, Western blot analysis. It is important to emphasize that these antibodies do not react with H. capsulatum antigen, since these two fungi share the same endemic regions in Latin America, and until now, there has been a high degree of cross-reactivity between them in serological and intradermal tests (12) .
These monoclonal antibodies may be directly suitable for diagnostic systems in which polyclonal or cross-reactive monoclonal antibodies against P. brasiliensis are used. For example, such monoclonal antibodies may supersede the existing hyperimmune sera used in direct immunofluorescence testing, which has known cross-reactive properties (8) . In addition, these monoclonal antibodies can be used as positive controls in immunodiffusion and immunoelectrophoresis techniques (3, 24) . However, their most important use may come in the development of a two-site ELISA for the detection of circulating antigen (4, 14, 29) .
Recently, much of the work defining species-specific epitopes for P. brasiliensis has focused on a 43-kilodalton glycoprotein (26) . Although this molecule has been shown to be recognized by sera from patients, data on its crossreactivity with other dimorphic fungi are not definitive (21) . If the species-specific epitope(s) defined by our monoclonal antibodies is recognized by sera from patients, it may well complement, or improve on, the use of the 43-kilodalton molecule.
